Skip to content

Effect of different concentrations of intraperitoneal bupivacaine on postoperative outcome in morbidly obese patients undergoing laparoscopic bariatric surgery

Effect of different concentrations of intraperitoneal bupivacaine on postoperative outcome in morbidly obese patients undergoing laparoscopic bariatric surgery - effect of different concentrations of intraperitoneal bupivacaine on pain and respiratory functions post bariatric surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038595
Enrollment
120
Registered
2019-11-15
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recruiting

Interventions

group 1 placebo group (n=40): patients receive 40 ml of normal saline 0.9% will be streamed at the surgical site and the other half will be streamed into the coelomic cavity prior to deflation grou

Sponsors

Mansoura university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: morbidly obese patients undergoing laparascoic bariatric surgery whose body mass index >35 . ASA I and II.

Exclusion criteria

Exclusion criteria: patient refusal,neuromuscular diseases (as myopathies, myasthenia gravie),psychiatric, hepatic, renal and cardiac diseases,known intolerance to the study drugs or patients converted to open surgery.

Design outcomes

Primary

MeasureTime frame
total analgesic requirements within 24 hours post operative

Secondary

MeasureTime frame
1-changes in respiratory functions measurements within 24 hours postoperative 2-time to first analgesic request 3-visual analogue scale measurement of pain within 24 hours postoperative 4-any reported side effects as difficulty of breathing, nusea or vomiting 5-return of bowel function

Countries

Africa

Contacts

Public Contactmohammed hegazy

Mansoura university anesthesia ans surgical intensive care department

dr_mhegazy7000@mans.edu.eg00201002025982

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026